MeiraGTx Holdings plc Operating Cash Flow
MeiraGTx Holdings plc (MGTX) reported Operating Cash Flow of -$20.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$38.54M.
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $17.81M.
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $46.63M.
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$12.21M.
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for fiscal 2025 was -$46.36M.
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for fiscal 2024 was -$104.50M.
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for fiscal 2023 was -$105.36M.
- MeiraGTx Holdings plc net cash provided by (used in) operating activities for fiscal 2022 was -$73.10M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$38.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$20.73M 10-Q · filed 2026-08-13 | $25.90M derived: sum of 3 quarters · filed 2026-08-13 | $13.69M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $17.81M 10-Q · filed 2026-05-14 | $64.44M derived: sum of 2 quarters · filed 2026-05-14 | $52.23M derived: sum of 3 quarters · filed 2026-05-14 | $8.28M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $46.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $34.42M derived: sum of 2 quarters · filed 2026-03-30 | -$9.53M derived: sum of 3 quarters · filed 2026-08-13 | -$46.36M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$12.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$56.16M derived: sum of 2 quarters · filed 2026-08-13 | -$92.99M 10-Q · filed 2025-11-13 | -$116.27M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$43.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$80.78M 10-Q · filed 2026-08-13 | -$104.05M derived: sum of 3 quarters · filed 2026-08-13 | -$129.07M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$36.83M 10-Q · filed 2026-05-14 | -$60.10M derived: sum of 2 quarters · filed 2026-05-14 | -$85.13M derived: sum of 3 quarters · filed 2026-05-14 | -$104.58M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$23.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$48.30M derived: sum of 2 quarters · filed 2026-03-30 | -$67.75M derived: sum of 3 quarters · filed 2026-03-30 | -$104.50M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$25.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$44.48M derived: sum of 2 quarters · filed 2025-11-13 | -$81.22M 10-Q · filed 2025-11-13 | -$95.77M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$19.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$56.20M 10-Q · filed 2025-08-14 | -$70.74M derived: sum of 3 quarters · filed 2025-08-14 | -$95.16M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$36.74M 10-Q · filed 2025-05-13 | -$51.29M derived: sum of 2 quarters · filed 2025-05-13 | -$75.70M derived: sum of 3 quarters · filed 2025-05-13 | -$104.71M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$14.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$38.96M derived: sum of 2 quarters · filed 2025-03-13 | -$67.97M derived: sum of 3 quarters · filed 2025-03-13 | -$105.36M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$24.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$53.43M derived: sum of 2 quarters · filed 2024-11-13 | -$90.82M 10-Q · filed 2024-11-13 | -$107.08M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$29.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$66.40M 10-Q · filed 2024-08-12 | -$82.67M derived: sum of 3 quarters · filed 2024-08-12 | -$103.40M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$37.39M 10-Q · filed 2024-05-09 | -$53.66M derived: sum of 2 quarters · filed 2024-05-09 | -$74.39M derived: sum of 3 quarters · filed 2024-05-09 | -$102.19M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$16.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$36.99M derived: sum of 2 quarters · filed 2024-03-15 | -$64.80M derived: sum of 3 quarters · filed 2024-03-15 | -$73.10M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | -$20.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$48.53M derived: sum of 2 quarters · filed 2023-11-14 | -$56.83M 10-Q · filed 2023-11-14 | -$38.00M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$27.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$36.10M 10-Q · filed 2023-08-10 | -$17.28M derived: sum of 3 quarters · filed 2023-08-10 | -$34.46M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$8.30M 10-Q · filed 2023-05-11 | $10.53M derived: sum of 2 quarters · filed 2023-05-11 | -$6.65M derived: sum of 3 quarters · filed 2023-05-11 | -$27.91M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $18.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.65M derived: sum of 2 quarters · filed 2023-03-14 | -$19.62M derived: sum of 3 quarters · filed 2023-03-14 | -$10.53M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | -$17.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$38.44M derived: sum of 2 quarters · filed 2022-11-10 | -$29.36M 10-Q · filed 2022-11-10 | -$58.92M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$21.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$12.18M 10-Q · filed 2022-08-11 | -$41.74M derived: sum of 3 quarters · filed 2022-08-11 | -$50.88M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $9.09M 10-Q · filed 2022-05-12 | -$20.48M derived: sum of 2 quarters · filed 2022-05-12 | -$29.62M derived: sum of 3 quarters · filed 2022-05-12 | -$42.50M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$29.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$38.70M derived: sum of 2 quarters · filed 2022-03-10 | -$51.58M derived: sum of 3 quarters · filed 2022-03-10 | -$63.97M 10-K · filed 2022-03-10 | -$63.97M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$9.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$22.02M derived: sum of 2 quarters · filed 2021-11-10 | -$34.41M 10-Q · filed 2021-11-10 | -$34.41M 10-Q · filed 2020-11-05 | -$56.38M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$12.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$25.26M 10-Q · filed 2021-08-11 | -$25.26M 10-Q · filed 2020-08-06 | -$47.24M derived: sum of 3 quarters · filed 2021-08-11 | -$65.64M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | -$12.38M 10-Q · filed 2021-05-11 | -$12.38M 10-Q · filed 2020-05-07 | -$34.36M derived: sum of 2 quarters · filed 2021-05-11 | -$52.76M derived: sum of 3 quarters · filed 2021-05-11 | -$74.51M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | -$21.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$40.38M derived: sum of 2 quarters · filed 2021-03-11 | -$62.12M derived: sum of 3 quarters · filed 2021-03-11 | $20.04M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$18.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$40.15M derived: sum of 2 quarters · filed 2020-11-05 | $42.02M 10-Q · filed 2020-11-05 | $30.55M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$21.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $60.42M 10-Q · filed 2020-08-06 | $48.95M derived: sum of 3 quarters · filed 2020-08-06 | $37.96M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $82.17M 10-Q · filed 2020-05-07 | $70.70M derived: sum of 2 quarters · filed 2020-05-07 | $59.70M derived: sum of 3 quarters · filed 2020-05-07 | $40.67M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$11.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$22.46M derived: sum of 2 quarters · filed 2020-03-11 | -$41.49M derived: sum of 3 quarters · filed 2020-03-11 | -$58.89M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | -$10.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$30.02M derived: sum of 2 quarters · filed 2019-11-07 | -$47.42M 10-Q · filed 2019-11-07 | -$51.13M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$19.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$36.43M 10-Q · filed 2019-08-07 | -$40.13M derived: sum of 3 quarters · filed 2019-08-07 | -$43.95M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$17.40M 10-Q · filed 2019-05-14 | -$21.11M derived: sum of 2 quarters · filed 2019-05-14 | -$24.92M derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | -$3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$7.52M derived: sum of 2 quarters · filed 2019-03-26 | -$18.06M 10-K · filed 2019-03-26 | |||||
| 2017-09-30 | -$3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$14.35M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$10.53M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |